Project Grant HT94252510907
Award Date 9/30/25
Completion Date 9/29/28
Dollars Obligated $2.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
- The University of Pittsburgh is the recipient of a $1,272,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant, titled "The Pittsburgh ASPIRES Bridge Builder Project: Connecting Advocates, Scientists, Patients, and Institutions for Research Expansion in Sarcoma," is intended to support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public....
- This federal Project Grant award of $673,197.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the University of Pittsburgh to harmonize and analyze multi-omic data on severe traumatic brain injury. The research aims to transform healthcare for military service members and the broader public by developing innovative medical solutions to address critical health challenges. The project will be...
- The University of Pittsburgh has been awarded a $747,131 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 10, 2024, supports the development of an Extracorporeal Perfusion System (EPS) for composite tissue regeneration. This research effort aims to advance innovative medical technologies to improve health outcomes for military service members and the broader public. The grant will fund a...
- The University of Pittsburgh was awarded a $925,680 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 1, 2023 to July 31, 2027 targeting the IGFBP2-SRC signaling axis to block metastatic spread and tumor-mesothelial crosstalk. Through this research, the University aims to develop medical solutions for the battlefield by investigating approaches to prevent cancer metastasis. The Military...
- The University of Pittsburgh - Of the Commonwealth System of Higher Education (University of Pittsburgh) was awarded a $1,246,455 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research to characterize a novel class of non-competitive androgen receptor antagonists from May 15, 2023 to May 14, 2026. The Military Medical Research and Development program aims to transform military and public health...
- The University of Pittsburgh received a $454,142.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "FERROPTOSIS AS A METABOLIC VULNERABILITY OF CYCLIN E-HIGH OVARIAN CANCER". This 2-year research project, with a performance period from May 2024 to May 2026, aims to investigate metabolic vulnerabilities in a specific type of ovarian cancer. The University of Pittsburgh is the primary...
- The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- This Project Grant award, titled "TARGETING LYSOSOMAL PATHWAYS TO IMPROVE HOST IMMUNITY POST CORONAVIRAL INFECTIONS," is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $1,572,933 award to the University of Pittsburgh is effective from January 1, 2025 through December 31, 2028. The objective of this research project is to investigate novel approaches for improving host immune responses following coronavirus...
- The University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh, received a $724,997.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the project "RECOVERY OF TENDON INJURY BY TARGETING ITS ROOT CAUSE AND ENHANCING TENDON STEM CELLS." The grant period of performance is from July 1, 2023 to June 30, 2026. The project aims to conduct biomedical...
- This federal Project Grant award of $4,902,315.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a research project titled "UNDERSTANDING THE EFFECTS OF INTRACAVITARY CONDITIONING IN BREAST CANCER METASTATIC TO THE PLEURA OR THE PERITONEUM" at the University of Pittsburgh. The project aims to conduct advanced biomedical research focused on developing innovative medical solutions to address critical health challenges relevant to...